All partnering requests
Private Company
Pre-clinical models and platforms for sleep and circadian biology
  • Background
  • What we're looking for
  • What we can offer you
  • Q&A
Background

We are a global consumer health and well-being company committed to advancing science-based solutions that support healthier daily living. Sleep and circadian rhythms are fundamental regulators of human health, influencing cognition, metabolism, mood, and recovery. While pre-clinical models have been instrumental in understanding these processes, traditional mammalian systems are often low-throughput, costly, and increasingly misaligned with regulatory expectations. 

 

Non-animal and alternative model systems (e.g., Drosophila, in vitro neuronal systems, organ-on-chip platforms) are emerging as scalable, mechanistic tools to study sleep regulation and circadian biology. These systems enable interrogation of pathways such as melatonin signalling, neuronal excitability, and molecular clock dynamics. 

 

There is growing interest in applying these models to evaluate dietary bioactives and natural ingredients, including complex botanical extracts, for their impact on sleep onset, duration, and circadian alignment.

What we're looking for

We are seeking models and screening capabilities to assess the impact of bioactives on sleep and circadian biology.

Solutions of interest include:
  • Non-animal in vivo models (e.g., Drosophila melanogaster) with validated sleep/circadian readouts.
  • In vitro systems (e.g., neuronal cultures, reporter assays, organoids) capturing circadian or sleep-relevant mechanisms
  • Organ-on-chip/microphysiological systems modelling neuronal or circadian function
  • Platforms that provide indicators of sleep-like behaviour (e.g., movement/inactivity/waking) or biological rhythms (e.g., timing/consistency/strength)
Our must-have requirements are:
  • Does not use live animal models, or animal tissues, as the experimental system. Animal is defined as ‘any non-human vertebrate or cephalopod’ (commercially available animal derived cell lines and reagents are acceptable, though not preferred).
  • Capable of testing dietary or natural ingredients/complex botanical extracts
  • Provides at least one quantifiable sleep or circadian readout
Our nice-to-have's are:
  • Demonstrated reproducibility and robustness
  • Medium-throughput or scalable screening capability
  • Evidence of translation to human biology or pharmacological benchmarks
  • Mechanistic resolution (e.g., melatonin receptor activity, clock gene reporters, neuronal signaling)
  • Ability to assess both sleep and circadian endpoints
  • Capability to run studies externally on behalf of sponsor
What's out of scope:
  • Systems unable to accommodate complex bioactives
Acceptable technology readiness levels (TRL):
Levels 3-9
What we can offer you
Eligible partnership models:
Sponsored researchCo-developmentPilot or trial engagementFee-for-service
Benefits:
Sponsored Research
Funding is proposal dependent, but an accepted proposal could expect support in the range of 50,000 - 150,000 USD (milestone dependent) with the potential for follow-on funding.
Expertise
Partners will interact with a project lead to mutually develop a project plan and engage in regular meetings to ensure success. Partners will have access to our experts as appropriate.
Q&A with the company

The Q&A is now closed.

Sort by:
Q.
Hello, I would with larval zebrafish. They are vertebrate but are not protected by Uk or EU animal ethics as pre-free-feeding stage (i.e. considered as eggs). Would you consider a proposal using them? best Caroline
1
A.
Thanks for the question, Caroline. Unfortunately, vertebrate models are out of scope for this RFP so while the approach is scientifically relevant it would not be considered.
Team Member, Reviewer, Private Company
July 17, 2026
Is this response helpful?
0
0
Q.
Hi, do you have any timelines in mind for an academic partnership on an in vitro screen using human stem cells? 6 months? 1 year?
1
A.
Thank you for your question, Kaiser. We are flexible on timelines and would align these with the scope of the proposal. Both 6 months and 1 year would be acceptable timelines depending on pilot experiments and overall project objectives.
Team Member, Reviewer, Private Company
August 7, 2026
Is this response helpful?
0
0
Q.
We patented a ready to use stable HA+ECM matrix (animal-free) for neuronal culture, adaptable to screening/biochips. How can we collaborate on your sleep/circadian projects?"
1
A.
Thank you for your response and for sharing your technology. We are primarily looking for complete, integrated system level solutions rather than individual components. However, please feel free to submit a proposal if you believe your technology aligns with this brief.
Team Member, Reviewer, Private Company
June 30, 2026
Is this response helpful?
0
0
Q.
“Describe your mechanism for improving sleep and circadian alignment, and explain how you validate next‑day performance without grogginess.”
1
A.
Thank you for your response. For this particular opportunity, we are ideally looking for platforms that are mechanism- and target-agnostic.
Team Member, Reviewer, Private Company
July 2, 2026
Is this response helpful?
0
0
Q.
Would a human translational screening platform using wearable physiology and AI to quantify sleep and circadian responses to dietary bioactives be considered within scope as a complementary validation platform?
1
A.
Thanks for your question and interest. The focus on the RFP is for a preclinical platform prior to testing in humans, so unfortunately, human clinical tools are out of scope.
Team Member, Reviewer, Private Company
July 13, 2026
Is this response helpful?
0
0
Q.
Do you have a defined panel of natural ingredients/botanical extracts you're looking to test, or are you also open to evaluating novel or proprietary compounds submitted by a partner?
CC
Casey Candebat, , Tulane University
July 16, 2026
1
A.
Thanks for the question, Casey. The purpose of the RFP is testing platforms and not a search for functional materials or compounds. We have defined materials we are interested in testing, however, if a potential partner, having satisfied all the other requirements, suggested materials for testing we would consider it. Submissions focused entirely on a partner's proprietary compound(s) are not of interest.
Team Member, Reviewer, Private Company
July 17, 2026
Is this response helpful?
0
0
Q.
When preparing the budget, can Facilities & Administration (overhead) be included?
KM
Kimberly Massengill, Research Development, University of Kentucky
July 23, 2026
1
A.
Thanks for your question, Kimberly. If they writing a proposal and are including an estimate of budget, yes, it would be helpful to include all potential costs for the project.
Team Member, Reviewer, Private Company
July 27, 2026
Is this response helpful?
0
0
Q.
Can you please let us know what countries are involved? Our University in the US restricts awards from certain countries.
1
A.
Thanks for your interest, Brian. We are a multi-national company. If you'd like to provide a list of restricted countries, we can review it.
Team Member, Reviewer, Private Company
July 23, 2026
Is this response helpful?
0
0
Q.
How many bioactives are you interested in screening and analyzing? Is the primary goal screening?
1
A.
Thanks for your question, Shihoko. We're looking for a platform with sufficient throughput to assess ~50 experimental conditions. While screening is one application, we'd also want to use it more broadly to support a range of future research questions and projects.
Team Member, Reviewer, Private Company
July 27, 2026
Is this response helpful?
0
0
Q.
Hello, what is your budget criteria? what do you fund? Do you cover staff and DI research costs only? Do you cover any overheads? What don't you fund ?Thank you
MM
Manjeet Mundey, Research Development, University of Nottingham
July 28, 2026
1
A.
Thank you for the question, Manjeet. At this stage, we'd welcome the full anticipated project budget, including all applicable costs and overheads where relevant; an estimate to the expected order of magnitude is sufficient and does not need to be exact.
Team Member, Reviewer, Private Company
July 29, 2026
Is this response helpful?
0
0
Sign up to access the full partnering request.
View the details of this request and connect directly with corporate R&D teams at Fortune 500 companies.
Submit Proposal
Complete
Refine recommendations
Is this request relevant to you?
Eligible partners
Academic researchersStartupsSuppliersService providers (CROs/CMOs)Consultants
Seeking partners focused on
Analytical ChemistryBiochemistryBioinformaticsBiological ComplexityBiomolecular ProcessesBiopharmaceuticsBiophysicsBotanyCarbohydrate BiochemistryCell Biology
33 more

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.